Again, one successful year behind us! I'm very grateful for all our group members and collaborators for all the hard work! There have been ups but also downs, and to be able to celebrate the real successes, one also needs to fail. The best part of failing is that one can learn and grow. And alongside, also mentor for the others not to repeat the same mistakes. Although we learn every single day when we do science, that's the heart of it, there is still so much space for growth. As we discussed in our this year's last group meeting, there are a lot of great aims and things to be achieved for the next year. So I'm curiously waiting for the next year, can it even be better than the current one? We will see... Before that, I wish a very merry Christmas and a relaxing holiday break for everyone. And above all, have a very happy and successful new year!
Hamed designed a chemistry christmas tree to cheer us up! It was very lovely! Also, big thanks for all the great gifts that I have received, I think we have already eaten half of those that managed to get to this photo... 😄 Nevertheless, I'm not sure if I was all that worth it...Transporter-Mediated Targeted Drug Delivery
Dec 20, 2025
Dec 11, 2025
Congratulations for Janne & Arun!
This week, we received great news when Janne and Arun were awarded UEF postdoctoral positions for the next 2 years. The competition was tough; there were 36 applications, 11 were interviewed, and only 6 applicants got the position in our Faculty of Health Sciences. So congratulations on both! As I'm being lazy now, I will post the text from LinkeIn:
Janne Tampio studies
prodrugs that utilize transporters to enhance drug targeting, working
with Assoc. Prof. Kristiina Huttunen. In his postdoctoral research, he
focuses on organic anion transporting polypeptides (OATPs) for
cell-type-specific brain drug delivery. His main scientific interests
include in vitro models and mass spectrometry. Over the coming years,
his main aim is to translate results from mouse models to the human
context, in collaboration with Prof. Annakaisa Haapasalo. Furthermore,
bioanalytical methods applied with Assoc. Prof. Marko Lehtonen and
international partners will reveal transporter expression profiles and
highlight the benefits of targeted drug delivery.
Arun
Tonduru is developing automated workflows that integrate molecular
dynamics (MD) into virtual screening to boost hit rates in drug
discovery. This work is carried out in collaboration with Prof. Antti
Poso and Orion Pharma. Alongside this, he continues his research on OATP
transporters, focusing particularly on OATP1B1 and OATP2B1. For
OATP1B1, his goals include investigating drug–drug interactions that
arise from transporter inhibition and identifying structural
determinants of inhibition by peptides — in collaboration with Assoc.
Prof. Kristiina Huttunen and Dr. Carolina Säll (Novo Nordisk). Another
major aim is to predict how OATP1B1 mutations affect the transport of
substrates and inhibitors, in collaboration with Prof. Tetsuya Terasaki
and Keio University, Japan.
Nov 30, 2025
Congratulation Jussi!
Finally, Jussi made it and successfully defended his Ph.D. thesis, which was carried out during the years 2014-2019. What then happened, well, we call it life! 😍Jussi was the first to start his Ph.D. in this group, but not the first to graduate, but who cares, he has had a great career in our University Hospital Pharmacy, after 2019. And most importantly, the work he did during his Ph.D. has paved the way, at least 5 other doctoral candidates who managed to graduate before him, and there are still many Ph.D. works coming out afterwards. So congratulations, Jussi! And big thanks for Prof. Tapani Viitala, for the great day!





